The National Lymphoedema Practitioners Register (NLPR, the Register) is the only recognised register of Lymphoedema Practitioners in Australia and New Zealand. Consumers, carers and referrers can be assured that only practitioners who meet the rigorous standards to become an ALA Accredited Practitioner are eligible to appear on the register.
The NLPR Committee, under the auspices of the Australasian Lymphology Association (ALA), has established a rigorous, independent and transparent process in line with other self-regulation schemes for health practitioners to ensure the quality of ALA Accredited Practitioners. ALA Accredited Practitioners must show they go above and beyond the requirements of other health practitioners to demonstrate their dedication, professionalism and expertise in working with people with lymphoedema. Broadly, those requirements are:
Demonstrated commitment to excellence in lymphoedema management, research and education through ongoing full membership of the ALA
Undergraduate and/or post-graduate qualification in a relevant health discipline
Registration with the relevant authority or, in the case of remedial massage therapists, membership of a recognised professional body
Successful completion of a recognised Lymphoedema Management Course
Maintain relevant skills and knowledge through participation in lymphoedema-specific continuing professional development
Current professional indemnity insurance.
For more information about these requirements please refer to the NLPR Guidelines.
Maintain and promote professional standards of practice for lymphoedema management.
Maintain a current register of lymphoedema practitioners. To find a practitioner in your area, follow this link
Distribute the register to health professionals, consumers, health insurance companies, and other interested persons.
Assist lymphoedema organisations, consumers and lymphoedema therapists to advocate for better health insurance rebates for lymphoedema treatment.
Enable the ALA to provide government bodies with current information on varying access to lymphoedema treatment across the regions.
Encourage collaborative lymphoedema research and a better understanding of the prevalence of lymphoedema in Australia and New Zealand.